Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-002586-38Phase 4Active
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Cholecalciferol arm with Placebo arm (2 arms). Primary endpoint: Primary: Change in parathyroid hormone levels at 12 weeks. Started Aug 2011; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-002586-38.